DLC1 and cancer: In comparison, genomic deletion and/or aberrant methylation occurring frequently for DLC-1 in different human cancers represent the more rigid mechanism(s) necessary for tumor cells to achieve a complete knock-down of the tumor suppressor functions of DLC-1.